Related Experiment Video
Updated: Mar 21, 2026

Fabrication of a Master Mold for Microneedles with a Micron-sized Air-vent Hole
Published on: December 5, 2025
Systemic delivery of artemether by dissolving microneedles
Yuqin Qiu1, Chun Li1, Suohui Zhang1
1Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
Dissolving microneedles effectively deliver poorly water-soluble drugs like artemether (ARM) transdermally. This minimally invasive approach shows comparable bioavailability and therapeutic effects to injections, offering a promising alternative for systemic drug delivery.
Area of Science:
- Pharmaceutical Sciences
- Biomaterials Engineering
- Drug Delivery Systems
Background:
- Transdermal drug delivery using dissolving microneedles (DMNs) offers a minimally invasive alternative to traditional methods.
- Systemic delivery of poorly water-soluble drugs via DMNs remains a significant challenge.
- Artemether (ARM), a poorly water-soluble antimalarial drug, serves as a model for developing advanced drug delivery systems.
Purpose of the Study:
- To develop and evaluate artemether (ARM)-loaded dissolving microneedles (DMNs) for efficient transdermal delivery.
- To assess the skin penetration, systemic absorption, and pharmacokinetic profile of ARM delivered via DMNs.
- To investigate the therapeutic efficacy of ARM-loaded DMNs in a relevant preclinical model.
Main Methods:
- Fabrication of ARM-loaded DMNs and characterization of their drug loading and release properties.
- Confocal laser scanning microscopy (CLSM) to visualize skin micro-conduits and determine needle insertion depth.
- In vivo pharmacokinetic studies in rats and pharmacodynamic evaluation in collagen-induced arthritis (CIA) rat models.
Main Results:
- DMNs successfully created micro-conduits in the skin, with an insertion depth of approximately 270μm.
- Maximum skin delivery of ARM reached 72.67±2.69% of the initial dose.
- Pharmacokinetic studies revealed a dose-dependent profile, with DMNs achieving comparable bioavailability and AUC to intramuscular injection, but with sustained plasma concentrations at 8h.
- Pharmacodynamic studies demonstrated that ARM-loaded DMNs effectively reversed paw edema in CIA rats, similar to intramuscular ARM.
Conclusions:
- Developed ARM-loaded DMNs provide an effective and minimally invasive strategy for the systemic delivery of poorly water-soluble drugs.
- This transdermal approach offers comparable therapeutic outcomes to traditional intramuscular injections.
- DMNs represent a promising platform for improving drug delivery and patient compliance for challenging drug molecules.
Related Concept Videos
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...

